Featured Research

from universities, journals, and other organizations

New light on the mechanism of Parkinson’s disease

Date:
September 8, 2010
Source:
The Biochemical Society
Summary:
A significant number of Parkinson’s disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions. In a new paper, researchers demonstrate that a family of proteins, the 14-3-3 proteins, interact with LRRK2.

A significant number of Parkinson's disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin).

However, little is understood about how it is regulated or functions. In a new paper in the Signal Knowledge Environment of the Biochemical Journal, Dario Alessi and colleagues from the University of Dundee demonstrate that a family of proteins, the 14-3-3 proteins, interact with LRRK2.

Mutations of the gene responsible for expressing LRRK2 have been linked to an increased risk of Parkinson's and Crohn's diseases; the researchers found that five of the six most common pathogenic mutations of LRRK2 affect its ability to bind with 14-3-3 proteins and alter cellular localization -- but not kinase activity -- of LRRK2. The mutated forms of LRRK2 that fail to bind 14-3-3 proteins accumulate within discrete cytoplasmic pools perhaps resembling inclusion bodies that contain misfolded protein that may be related to the pathology.

This clearer understanding of how LRRK2 is regulated is likely to open promising avenues to Parkinson's disease researchers.

Professor Mark Lemmon, Deputy Chair for BJ Signal, commented that "although this work shows that understanding LRRK2 mutations is definitely not simple, the Alessi group has discovered important new aspects of LRRK2 regulation that help enormously in thinking about what might be going wrong. The path opened up by this study will be very illuminating for understanding LRRK2 itself, which has been something of an enigma, and its role in Parkinson's disease."


Story Source:

The above story is based on materials provided by The Biochemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. R.Jeremy Nichols, Nicolas Dzamko, NicholasA. Morrice, DavidG. Campbell, Maria Deak, Alban Ordureau, Thomas Macartney, Youren Tong, Jie Shen, AlanR. Prescott, DarioR. Alessi. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochemical Journal, 2010; 430 (3): 393 DOI: 10.1042/BJ20100483

Cite This Page:

The Biochemical Society. "New light on the mechanism of Parkinson’s disease." ScienceDaily. ScienceDaily, 8 September 2010. <www.sciencedaily.com/releases/2010/09/100901073407.htm>.
The Biochemical Society. (2010, September 8). New light on the mechanism of Parkinson’s disease. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/09/100901073407.htm
The Biochemical Society. "New light on the mechanism of Parkinson’s disease." ScienceDaily. www.sciencedaily.com/releases/2010/09/100901073407.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins